Teva Pharmaceutical Industries ADR (TEVA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2014 | 06-2014 | 03-2014 | 12-2013 | 09-2013 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 2,348,000 | 1,485,000 | 740,000 | 1,253,000 | 876,000 |
| Depreciation Amortization | 1,139,000 | 778,000 | 404,000 | 1,642,000 | 1,206,000 |
| Income taxes - deferred | -223,000 | -124,000 | -61,000 | -1,380,000 | -666,000 |
| Other Working Capital | -217,000 | -337,000 | -248,000 | 968,000 | 609,000 |
| Other Operating Activity | 328,000 | 149,000 | 63,000 | 754,000 | 396,000 |
| Operating Cash Flow | $3,375,000 | $1,951,000 | $898,000 | $3,237,000 | $2,421,000 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -472,000 | -275,000 | -207,000 | -844,000 | -544,000 |
| Net Acquisitions | -363,000 | -163,000 | -163,000 | -39,000 | -39,000 |
| Purchase Of Investment | -242,000 | -116,000 | -8,000 | -160,000 | -157,000 |
| Other Investing Activity | -26,000 | -21,000 | -10,000 | -104,000 | -91,000 |
| Investing Cash Flow | $-1,103,000 | $-575,000 | $-388,000 | $-1,147,000 | $-831,000 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | -372,000 | -274,000 | 336,000 | 384,000 | N/A |
| Debt Issued | N/A | -2,000 | -2,000 | 338,000 | 2,000 |
| Debt Repayment | -797,000 | -785,000 | -767,000 | -3,133,000 | -2,005,000 |
| Common Stock Issued | 290,000 | 210,000 | 98,000 | 91,000 | 29,000 |
| Common Stock Repurchased | N/A | N/A | N/A | -497,000 | -497,000 |
| Dividend Paid | -884,000 | -590,000 | -291,000 | -1,089,000 | -813,000 |
| Other Financing Activity | -19,000 | -12,000 | -8,000 | 23,000 | 20,000 |
| Financing Cash Flow | $-1,782,000 | $-1,453,000 | $-634,000 | $-3,883,000 | $-3,264,000 |
| Exchange Rate Effect | -55,000 | -12,000 | -13,000 | -48,000 | -57,000 |
| Beginning Cash Position | 1,038,000 | 1,038,000 | 1,038,000 | 2,879,000 | 2,879,000 |
| End Cash Position | 1,473,000 | 949,000 | 901,000 | 1,038,000 | 1,148,000 |
| Net Cash Flow | $435,000 | $-89,000 | $-137,000 | $-1,841,000 | $-1,731,000 |
| Free Cash Flow | |||||
| Operating Cash Flow | 3,375,000 | 1,951,000 | 898,000 | 3,237,000 | 2,421,000 |
| Capital Expenditure | -629,000 | -417,000 | -225,000 | -1,031,000 | -717,000 |
| Free Cash Flow | 2,746,000 | 1,534,000 | 673,000 | 2,206,000 | 1,704,000 |